TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/19/22 16:45 | 12/15/22 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jones Michael L | NC | O | Exec. Di | S | -5 | 10.90 | 0 | 0 | -4 | 11 | D | ||||||||||||||
12/2/22 18:36 | 12/1/22 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jones Michael L | NC | O | Exec. Di | M.d | 12 | 1.42 | 0 | 9 | 331 | 11 | D | ||||||||||||||
12/2/22 18:36 | 12/1/22 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jones Michael L | NC | O | Exec. Di | S.d | -112 | 13.01 | 0 | -9 | -43 | 11 | D | ||||||||||||||
3/3/22 17:04 | 3/1/22 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jones Michael L | NC | O | Exec. Di | M.d | 11 | 4.73 | 0 | 2 | 26 | 11 | D | ||||||||||||||
3/3/22 17:04 | 3/1/22 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jones Michael L | NC | O | Exec. Di | S.d | -40 | 17.20 | 0 | -2 | -17 | 11 | D | ||||||||||||||
3/22/21 16:19 | 3/18/21 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jones Michael L | NC | O | Exec. Di | M.d | 16 | 3.51 | 0 | 5 | 531 | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |